期刊文献+

血清胱抑素C对老年高血压病肾功能损害诊治的临床意义 被引量:17

Clinical Significance of Serum Cystatin C in Treating Elderly Hypertensive Renal Damage
下载PDF
导出
摘要 目的探讨血清胱抑素C(CysC)在老年高血压病肾功能损害中的应用价值。方法检测高血压患者的血清CysC、肌酐(Cr)及尿酸(UA)水平。比较不同Cr水平组患者CysC和UA水平的差异。结果不同Cr水平组患者的CysC水平间差异明显,经两两比较,差异均有统计学意义(P<0.05);Cr水平正常组与其他3组比较,UA水平间差异均有统计学意义(P<0.05),其他3组UA水平两两比较差异无统计学意义(P>0.05)。Cr水平正常组中,CysC正常者35例,CysC升高者20例,其Cr水平间差异有统计学意义(P<0.05)。通过控制血压、改善肾血流等保肾治疗,Cr、CysC水平均较治疗前明显下降(P<0.05)。结论血清CysC是反映高血压早期肾功能损害的内源性敏感指标,在早期诊断高血压肾损伤、评价肾功能不全程度及治疗效果判定方面具有重要的临床价值。 Objective To study the application value of serum cystatin C (CysC) in hypertensive patients with im- paired renal function. Methods Tested the levels of serum CysC, Creatinine (Cr) and uric acid (UA) and made a compari- son between CysC and UA in patients with different Cr. Results The difference of CysC in patients with different Cr was signifi-cant ( P 〈 0. 05 ) ; the difference of UA between the patients with normal Cr and the other three groups was significant ( P 〈 0. 05) ; the difference of UA between the other three groups was not significant (P 〉 0. 05 ). In the patients with normal Cr, there were 35 patients with normal CysC, 20 patients with CysC increasing, the difference between them was also significant (P〈 0. 05). After renal protective treatment such as controlling blood pressure, improving renal blood flow, the levels of Cr and CysC all had an obvious decrease than before (P 〈 0. 05 ). Conclusion A sensitive endogenous indicator for early hypertensive renal impairment, serum CysC plays a very important role in early diagnosis of hypertensive renal injury, assessment of renal dys- function and judgment of therapeutic effect.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第8期911-912,共2页 Chinese General Practice
基金 合肥市科技局科研计划项目(2009年度)
关键词 高血压 肾损害 血清胱抑素C 肌酐 尿酸 Hypertension Kidney damage Serum cystatin C Creatinine Uric acid
  • 相关文献

参考文献5

  • 1Hohenstein K,Watschinger B. Hypertension and the kidney[J].Wiener Medizinische Wochenschrift,2008,(13-14):359-364.doi:10.1007/s10354-008-0558-3.
  • 2Taglieri N,Koenig W,Kaski JC. Cystatin C and cardiovascular risk[J].Clinical Chemistry,2009,(11):1932-1943.doi:10.1373/clinchem.2009.128397.
  • 3Prats M,Font R,Bardaj A. Cystatin C and cardiac hypertrophy in primary hypertension[J].Blood Pressure,2010,(01):20-25.doi:10.3109/08037050903416386.
  • 4McMurray MD,Trivax JE,McCullough PA. Serum cystatin C,renal filtration function,and left ventricular remodeling[J].Circ Heart Fail,2009,(02):86-89.doi:10.1161/CIRCHEARTFAILURE.109.856393.
  • 5董梅,孟祥红,佟爱华,李艳艳,吴纯.血清胱抑素C在评价糖尿病患者早期肾损伤中的价值[J].中国实验诊断学,2006,10(6):642-643. 被引量:32

二级参考文献5

  • 1Galteau MM,Guyon M,Gueguen R,Siest G.Determination of serum cystatin C:biological variation and reference values[J].Clin Chem Lab Med,2001,39(9):850.
  • 2Jimonsen O,Grubb A,Thysll H.Scand J Clin Invest,1985,45:97.
  • 3Abramhamson K,Olaffson I,Palsdottir A,et al.biochem J,1990:268 -287.
  • 4Finney H,Newman DJ,Gruber Werle P,et al.Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems[J].Clin Chem,1997,43:1016.
  • 5任豫申,许迅辉,丁小强.血清胱抑素C:在肌酐盲范围检测GFR的标志物[J].国外医学(泌尿系统分册),2002,22(5):318-320. 被引量:33

共引文献31

同被引文献175

  • 1周青霞.胱抑素C、尿β2微球蛋白在老年糖尿病患者早期肾损伤临床监测应用[J].中国老年学杂志,2014,34(2):528-529. 被引量:16
  • 2管乐,郑少雄.2型糖尿病肾病危险因素[J].中华肾脏病杂志,2006,22(1):18-18. 被引量:12
  • 3张建军.血清胱抑素与妊娠高血压疾病临床观察[J].医学研究杂志,2006,35(12):64-65. 被引量:3
  • 4陆福明,翁敏佳.红斑狼疮肾损害诊治进展[J].临床儿科杂志,2007,25(9):721-725. 被引量:3
  • 5Page MK, Bukki J, Luppa P, et al. Clinical value of cystatin C determination [ J ]. Clin Chim Acta, 2000, 297 (1/2) : 67 -72.
  • 6Turk V, Turk B, Guncar G, et al. Lysosomal cathepsins: structure, role in antigen process- ing and presentation, and cancer [ J ]. Adv Enzyme Regul, 2002, 42:285 - 303.
  • 7Wang B, Sun J, Kitamoto S, et al. Cathepsin S controls angiogenesis and tumor growth via matrix - derived angiogenic factors [ J ]. J Biol Chem, 2006, 281 (9) : 6020-6029.
  • 8Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of end organ dam- age in patients with essential hypertension[J]. Hypertens Res, 2003, 26 (11): 895 - 899.
  • 9Koenig W, Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for sec- ondary cardiovascular events: more than sim- ply a marker of glomerular filtration rate [ J ]. Clin Chem, 2005, 51 (2) : 321 -327.
  • 10Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C levels are decreased in acute myo- cardial infarction: effect of eystatin C G73Agenepolym orphism on plasma levels [ J ]. Int J Cardio, 2005, 101 (2) : 213 -217.

引证文献17

二级引证文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部